Dr Matt Cooper was appointed as the CRN Business Development and Marketing Director in February 2015, having previously been the Life Sciences Development Director since June 2014.
Matt gained a PhD in molecular virology in 1997 before joining AstraZeneca UK as a Clinical Research Scientist and then Study Manager. Over the next five years he managed phase II and III studies in a variety of therapy areas. In 2003 he returned to academia first in a Clinical Trials Unit at an NHS Foundation Trust, and later a Musculoskeletal Disease trials group at the Leeds Institute of Molecular Medicine.
He joined the Cancer Specialty within the CRN in December 2006 as Principal Fellow for Clinical Trials and was appointed as Assistant Director in 2009. In this role Matt helped to improve patient recruitment by the Network to the extent that one in five patients diagnosed with cancer now participate in clinical research – a figure without compare in any other country. He was also influential in developing alliances between industry and academic researchers to explore innovative uses for new compounds – an initiative he hopes to extend into new therapy areas in his current role.